256 related articles for article (PubMed ID: 17575122)
1. Membrane-bound interleukin (IL)-15 on renal tumor cells rescues natural killer cells from IL-2 starvation-induced apoptosis.
Wittnebel S; Da Rocha S; Giron-Michel J; Jalil A; Opolon P; Escudier B; Validire P; Khawam K; Chouaib S; Azzarone B; Caignard A
Cancer Res; 2007 Jun; 67(12):5594-9. PubMed ID: 17575122
[TBL] [Abstract][Full Text] [Related]
2. Human renal cancer cells express a novel membrane-bound interleukin-15 that induces, in response to the soluble interleukin-15 receptor alpha chain, epithelial-to-mesenchymal transition.
Khawam K; Giron-Michel J; Gu Y; Perier A; Giuliani M; Caignard A; Devocelle A; Ferrini S; Fabbi M; Charpentier B; Ludwig A; Chouaib S; Azzarone B; Eid P
Cancer Res; 2009 Feb; 69(4):1561-9. PubMed ID: 19190330
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy.
Varker KA; Kondadasula SV; Go MR; Lesinski GB; Ghosh-Berkebile R; Lehman A; Monk JP; Olencki T; Kendra K; Carson WE
Clin Cancer Res; 2006 Oct; 12(19):5850-8. PubMed ID: 17020993
[TBL] [Abstract][Full Text] [Related]
4. Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape.
Rayman P; Uzzo RG; Kolenko V; Bloom T; Cathcart MK; Molto L; Novick AC; Bukowski RM; Hamilton T; Finke JH
Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S81-7. PubMed ID: 10685665
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic markers and frequency predict functional capacity of natural killer cells infiltrating renal cell carcinoma.
Schleypen JS; Baur N; Kammerer R; Nelson PJ; Rohrmann K; Gröne EF; Hohenfellner M; Haferkamp A; Pohla H; Schendel DJ; Falk CS; Noessner E
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):718-25. PubMed ID: 16467081
[TBL] [Abstract][Full Text] [Related]
6. A programmed switch from IL-15- to IL-2-dependent activation in human NK cells.
Pillet AH; Bugault F; Thèze J; Chakrabarti LA; Rose T
J Immunol; 2009 May; 182(10):6267-77. PubMed ID: 19414780
[TBL] [Abstract][Full Text] [Related]
7. Bcl-xL is associated with the anti-apoptotic effect of IL-15 on the survival of CD56(dim) natural killer cells.
Zheng X; Wang Y; Wei H; Ling B; Sun R; Tian Z
Mol Immunol; 2008 May; 45(9):2559-69. PubMed ID: 18295891
[TBL] [Abstract][Full Text] [Related]
8. Renal cell carcinoma and natural killer cells: studies in a novel rat model in vitro and in vivo.
Winter BK; Wu S; Nelson AC; Pollack SB
Cancer Res; 1992 Nov; 52(22):6279-86. PubMed ID: 1423274
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells.
Ostberg JR; Dayanc BE; Yuan M; Oflazoglu E; Repasky EA
J Leukoc Biol; 2007 Nov; 82(5):1322-31. PubMed ID: 17711975
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-15 is a major regulator of the cell-microenvironment interactions in human renal cancer.
Giron-Michel J; Azzi S; Khawam K; Caignard A; Devocelle A; Perrier A; Chouaib S; Eid P; Azzarone B
Bull Cancer; 2011 May; 98(5):32-9. PubMed ID: 21609895
[TBL] [Abstract][Full Text] [Related]
11. Different NK cell developmental events require different levels of IL-15 trans-presentation.
Lee GA; Liou YH; Wang SW; Ko KL; Jiang ST; Liao NS
J Immunol; 2011 Aug; 187(3):1212-21. PubMed ID: 21715685
[TBL] [Abstract][Full Text] [Related]
12. [Tumor-immune system interaction in renal cell carcinoma and melanomas. Cytokine transcription in tumors at the time of surgical resection].
Zuber M; Filgueira L; Merlo A; Lüscher U; Juretic A; Spagnoli G; Harder F; Heberer M
Schweiz Med Wochenschr; 1994 Jun; 124(22):930-5. PubMed ID: 8029672
[TBL] [Abstract][Full Text] [Related]
13. A role for lymphotoxin in the acquisition of Ly49 receptors during NK cell development.
Lian RH; Chin RK; Nemeth HE; Libby SL; Fu YX; Kumar V
Eur J Immunol; 2004 Oct; 34(10):2699-707. PubMed ID: 15368286
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D.
Zhang C; Zhang J; Niu J; Zhou Z; Zhang J; Tian Z
Hum Immunol; 2008 Aug; 69(8):490-500. PubMed ID: 18619507
[TBL] [Abstract][Full Text] [Related]
15. Expression and possible function of IL-2 and IL-15 receptors on human uveal melanoma cells.
He YG; Mayhew E; Mellon J; Niederkorn JY
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4240-6. PubMed ID: 15557426
[TBL] [Abstract][Full Text] [Related]
16. Human Renal Normal, Tumoral, and Cancer Stem Cells Express Membrane-Bound Interleukin-15 Isoforms Displaying Different Functions.
Azzi S; Gallerne C; Romei C; Le Coz V; Gangemi R; Khawam K; Devocelle A; Gu Y; Bruno S; Ferrini S; Chouaib S; Eid P; Azzarone B; Giron-Michel J
Neoplasia; 2015 Jun; 17(6):509-17. PubMed ID: 26152359
[TBL] [Abstract][Full Text] [Related]
17. High DGK-α and disabled MAPK pathways cause dysfunction of human tumor-infiltrating CD8+ T cells that is reversible by pharmacologic intervention.
Prinz PU; Mendler AN; Masouris I; Durner L; Oberneder R; Noessner E
J Immunol; 2012 Jun; 188(12):5990-6000. PubMed ID: 22573804
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-2 activated microglia engulf tumor infiltrating T cells in the central nervous system.
Tamakawa N; Saio M; Suwa T; Ohe N; Yoshimura S; Iwama T; Shinoda J; Sakai N; Takami T
Int J Mol Med; 2004 Apr; 13(4):497-503. PubMed ID: 15010848
[TBL] [Abstract][Full Text] [Related]
19. Altered natural killer cell differentiation in CD34+ progenitors from chronic myeloid leukemia patients.
Carayol G; Giron-Michel J; Azzarone B; Castagna L; Cambier N; Mishal Z; Bourhis JH; Chouaib S; Caignard A
Oncogene; 2000 May; 19(23):2758-66. PubMed ID: 10851076
[TBL] [Abstract][Full Text] [Related]
20. Chemokine receptors expression and migration potential of tumor-infiltrating and peripheral-expanded Vgamma9Vdelta2 T cells from renal cell carcinoma patients.
Viey E; Lucas C; Romagne F; Escudier B; Chouaib S; Caignard A
J Immunother; 2008 Apr; 31(3):313-23. PubMed ID: 18317356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
